H1N1 influenza vaccine: Phase I started

Not-for-profit Fraunhofer USA Center for Molecular Biotechnology (Newark, Del.) began a single-blind, placebo-controlled, dose-escalation, U.S. Phase I trial in 80 healthy volunteers to evaluate 2 int...